The Spike Newspaper in the Eyes of My Son
Release time:
2022-04-06
■ Huang Ping Jianfeng Zhu Yong
Three years ago, 11 -year-old son always lost points in composition every exam. I was very distressed about this. I bought a lot of extracurricular literature books, but with little effect. As the saying goes, the power of role models is infinite, and parents' words and deeds have an extremely important impact on children. Later, I think that since I joined the peak, I have published many "tofu " in the peak newspaper, won the second prize for the 12th anniversary of the listing 20#, made a small appearance in the staff column, and also published several articles in local journals. Why don't you take these out to show off, frighten that smelly boy, and let him take his father as a small target to improve his writing level?
"son, your composition has been deducted 12 points. the whole article is scattered and the description is dry. if I were your Chinese teacher, I would have to deduct at least 18 points. "
The son bowed his head like a frosted eggplant. I refrained from laughing and slowly took out the "peak newspaper" of previous years from my bag, saying: "you should learn from dad, read more and write more. Take a look at the articles published by your father a few years ago. Here," Peak News ", an article published in Zhengerbajing, this one won the second prize, and these articles are Dad's columns. "
The son looked up with his eyes shining and grabbed the newspaper in my hand: "Dad, you're not bragging, are you? "
I choked back the stirring pride in my heart and showed understatement: "just wrote a few articles, which is a small thing for your father, and you should learn from him. "
son looked at the "peak newspaper" carefully, while pie mouth disdain, mouth hard mutter: "is normal. " But as an old father, his son's virtue is still clear. Seeing the newspaper that emits ink fragrance and is written by his most admired father, the inner touch and shock is definitely indispensable. However, the fine tradition inherited from his mother still needs to be shaken from time to time. I am too lazy to care about it. I carefully told my son about the history and origin of the "peak newspaper". by the way, I told him some simple ways to write with the existing "textbook " , such as clear and logical theme, concise language but full of emotion. Let him see more and learn more, there will always be a day to improve.
My son sipped his mouth and nodded with determination. I knew that my son had listened and the seeds had been planted. I waited for him to take root.
Later, my son's composition level began to improve slowly, and his points were deducted less and less. He often showed off in front of me. I know that the improvement of writing level is a slow process of moistening things silently, as long as it is good to move forward step by step. In this matter, it was the carrier of "Peak News" that touched the little heartstrings of his son.
However, there are still some unexpected developments - because I wrote about my emotional life in the column, which inexplicably ignited my son's gossip fire. This is probably also hereditary. Strange questions made me feel embarrassed from the beginning to become accustomed to it and then impatient.
"Dad, is it true that you wrote about your blind date with your mother in that article in the" Spike News "column? "
"Why do children ask so many questions and do their homework! "
"Dad, mom asked what does your seven-year itch mean? "
"......""
Dad, is it true that you said in your article that you bought flowers for my mother while shopping for vegetables? "
"Go away Go away, leave me alone!" "
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31